LifeMD, Inc.
LFMD
$3.90
-$0.19-4.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 51.04% | -0.89% | 3.35% | 7.83% | 1.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.04% | -0.89% | 3.35% | 7.83% | 1.49% |
| Cost of Revenue | 37.62% | 51.47% | 41.13% | 32.14% | 13.44% |
| Gross Profit | 53.19% | -6.90% | -1.32% | 4.58% | -0.20% |
| SG&A Expenses | 33.75% | -12.88% | -7.15% | -1.04% | 2.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 37.35% | 33.67% | 29.94% | 25.88% | 39.06% |
| Total Operating Expenses | 34.90% | -5.18% | -0.87% | 3.69% | 4.90% |
| Operating Income | 87.53% | 55.34% | 45.03% | 34.37% | -40.81% |
| Income Before Tax | 76.85% | 42.91% | 39.06% | 32.04% | -29.67% |
| Income Tax Expenses | -69.40% | -19.06% | 39.72% | 39.72% | 39.72% |
| Earnings from Continuing Operations | 76.65% | 42.10% | 37.37% | 30.58% | -29.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -130.59% | -113.99% | 28.93% | 58.39% | 80.09% |
| Net Income | 167.05% | 47.79% | 47.39% | 43.24% | -3.95% |
| EBIT | 87.53% | 55.34% | 45.03% | 34.37% | -40.81% |
| EBITDA | 95.75% | 56.71% | 44.96% | 33.14% | -49.54% |
| EPS Basic | 139.46% | 47.13% | 48.26% | 47.55% | 15.18% |
| Normalized Basic EPS | 76.73% | 44.32% | 44.80% | 45.68% | 10.58% |
| EPS Diluted | 138.12% | 45.93% | 47.13% | 46.29% | 14.56% |
| Normalized Diluted EPS | 76.50% | 44.07% | 44.58% | 45.49% | 10.58% |
| Average Basic Shares Outstanding | 10.22% | 9.80% | 12.53% | 17.23% | 20.90% |
| Average Diluted Shares Outstanding | 11.71% | 11.33% | 14.14% | 18.94% | 20.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 2.49% | -0.92% | -0.90% | -0.76% | 0.04% |